| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.76▼ | 4.77▼ | 4.77▼ | 4.87▼ | 5.02▼ |
| MA10 | 4.75▼ | 4.78▼ | 4.77▼ | 5.20▼ | 4.95▼ |
| MA20 | 4.77▼ | 4.79▼ | 4.82▼ | 5.12▼ | 5.69▼ |
| MA50 | 4.78▼ | 4.88▼ | 5.20▼ | 5.03▼ | 4.68▲ |
| MA100 | 4.78▼ | 5.23▼ | 5.16▼ | 5.80▼ | 3.20▲ |
| MA200 | 4.82▼ | 5.15▼ | 5.09▼ | 5.31▼ | 5.24▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.008▲ | 0.018▲ | -0.057▼ | -0.172▼ |
| RSI | 43.042▼ | 39.585▼ | 32.435▼ | 40.620▼ | 45.737▼ |
| STOCH | 69.697 | 50.926 | 38.889 | 20.427 | 29.232 |
| WILL %R | -47.826 | -66.667 | -76.000▼ | -93.913▼ | -84.234▼ |
| CCI | -40.460 | -59.848 | -113.303▼ | -107.186▼ | -63.474 |
| CDL | $IMRX Doji Candlestick Pattern Detected | Set Alert |
|
Tuesday, March 17, 2026 01:54 PM
Immuneering will present an analysis of circulating tumor DNA (ctDNA) from ≥64 patients with RAS-mutant solid tumors treated with atebimetinib, showing that acquired MAPK pathway alterations are ...
|
|
Tuesday, March 10, 2026 11:28 AM
Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that ...
|
|
Monday, March 02, 2026 01:48 PM
Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that management will present at the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/03/26 | 4.71 | 4.79 | 4.68 | 4.74 | 250,484 |
| 18/03/26 | 4.82 | 4.86 | 4.67 | 4.78 | 1,208,315 |
| 17/03/26 | 4.92 | 4.954 | 4.70 | 4.80 | 1,554,332 |
| 16/03/26 | 5.05 | 5.11 | 4.905 | 4.96 | 931,776 |
| 13/03/26 | 5.47 | 5.52 | 4.92 | 5.05 | 1,518,933 |
| 12/03/26 | 5.66 | 5.70 | 5.39 | 5.45 | 595,115 |
| 11/03/26 | 5.53 | 5.77 | 5.52 | 5.65 | 521,259 |
| 10/03/26 | 5.64 | 5.82 | 5.61 | 5.62 | 593,976 |
| 09/03/26 | 5.22 | 5.67 | 5.165 | 5.62 | 1,037,328 |
| 06/03/26 | 4.85 | 5.39 | 4.83 | 5.33 | 969,700 |
|
|
||||
|
|
||||
|
|